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Abstract.  To study molecular mechanisms underlying 
neuronal cell death, we have used sympathetic neurons 
from superior cervical ganglia which undergo pro- 
grammed cell death when deprived of nerve growth 
factor.  These neurons have been microinjected with 
expression vectors containing  cDNAs encoding 
selected proteins to test their regulatory influence over 
cell death.  Using this procedure, we have shown previ- 
ously that sympathetic neurons can be protected from 
NGF deprivation by the protooncogene Bcl-2. We now 
report that the E1B19K protein from adenovirus and 
the p35 protein from baculovirus also rescue neurons. 
Other adenoviral proteins,  E1A and E1B55K, have no 
effect on neuronal  survival.  E1B55K, known to block 
apoptosis mediated by p53 in proliferative cells, failed 
to rescue sympathetic neurons suggesting that p53 is 
not involved in neuronal death induced by NGF depri- 
vation. 
E1B19K and p35 were also coinjected with Bcl-Xs 
which blocks Bcl-2 function in lymphoid cells. Al- 
though BcI-Xs blocked the ability of Bcl-2 to rescue 
neurons,  it had no effect on survival that was depen- 
dent upon expression of E1B19K or p35. 
p 
ROGRAMMED cell death plays a key role during  de- 
velopment of the nervous system (for review see ref- 
erence 36), although  the molecular mechanisms  by 
which neurons die are unknown.  Epigenetic factors, such as 
neurotrophic factors, seem to promote neuronal  survival by 
blocking  an  intrinsic  cell death  program  (for review see 
references 26, 38). Recent identification of proteins that can 
block apoptosis may be used as tools to unravel pathways of 
cell death.  The Bcl-2  protooncogene (2, 44) is the proto- 
type of these anti-death proteins (1, 13, 16, 24, 31, 40), and 
a family of proteins homologous to Bcl-2 is now emerging 
(for review see reference 49). Among these, the Bcl-X gene 
is the most homologous to Bcl-2 (6) and encodes two splice 
variants termed Bcl-X1 and Bcl-Xs. Bcl-Xs lacks a 63-amino 
acid region that is conserved between different Bel-2 family 
members. Whereas BcI-X1 has anti-apoptotic  function, Bcl- 
Xs inhibits the ability of Bcl-2 to enhance the survival of tro- 
phic factor-deprived cells (6). 
Other anti-apoptotic  proteins,  with no obvious primary se- 
quence homology with members of the Bcl-2 family, have 
also been characterized.  Among these are the E1B19K and 
EIB55K proteins from adenovirus  and the p35 protein from 
baculovirus. 
The first two authors contributed equally to this work. 
Address all correspondence to Dr. Jean-Claude Martinou, Glaxo Insti- 
tute for  Molecular Biology,  14  Chem des Aulx,  1228  Plan-les-Ouates, 
Geneva, Switzerland. Tel.:  (41) 22 706 9822.  Fax: (41)  22 794 6965. 
The EIB gene encodes two major proteins,  the 19-kD and 
55-kD proteins which cooperate with E1A proteins to allow 
transformation  (3, 5, 34, 45). Although EIA alone is capable 
of stimulating cell proliferation,  this is accompanied by rapid 
cell degeneration  due to apoptosis. The E1B proteins over- 
come this effect thereby enhancing  cell transformation  (47). 
The 19-kD EIB protein can also block the cytotoxic action 
of tumor necrosis factor or of anti-FAS antibodies (18, 20, 
47), both of which induce apoptosis (25, 29). The induction 
of apoptosis by EtA is p53 dependent,  and both E1B19K and 
E1B55K inhibit  the apoptotic activity of p53 (12, 30, 39). 
The EIB55K protein interacts  with p53 and inhibits  its ac- 
tivity as a transcription  factor whereas the mechanism of  p53 
inhibition  by E1B19K is unknown. 
p35 was first characterized  in the Autographa californica 
nuclear polyhedrosis virus.  The protein has been shown to 
be  necessary  to  prevent  premature  cell  death  of virus- 
infected Spodoptera furgiperda (SF) insect cells (9).  The 
protein  is  also  expressed  and  used  by  other  strains  of 
baculoviruses (27).  It has been shown that p35 transfected 
in a mammalian neural cell line can block apoptosis induced 
by the withdrawal of serum or glucose or by calcium iono- 
phore (37). p35 also prevents apoptosis and rescues a ted-9 
mutant in the nematode C. elegans (43). 
These anti-apoptotic  proteins regulate key processes con- 
trolling apoptosis and are therefore likely to provide impor- 
tant insights into steps underlying  cell death.  Here we have 
tested the effect of E1A, EIB, and p35 on the survival of post- 
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sence of NGF (14, 32). We show that while EtA or E1B55K 
fail to affect neuronal survival, E1B19K and p35 block apop- 
tosis induced by NGF withdrawal. The mode of action of 
these proteins may be different from that of  Bcl-2 since coin- 
jected Bcl-Xs cannot block the actions of p35 or of EIB19K. 
Finally, we show that Bcl-Xs expression does not induce cell 
death of neurons in the presence of NGF, suggesting that 
Bcl-2 is not an essential component of the NGF survival 
pathway. 
Materials and Methods 
Sympathetic  neuron cultures:  sympathetic  neurons from superior cervical 
ganglia  (SCG)  t were cultured as previously  described (17). Briefly, SCG 
from newborn rats were dissociated in dispase  for 30 rain. Neurons were 
then m¢chanicaUy dissociated and plated at a low density (104/cm  2) in 3.5- 
cm petri dishes coated with collagen. During the first 4 d of culture, neurons 
were cultured in L¢ibowitz  medium, 5% rat serum, 0.75 ~g/ml 7S NGF 
(Boehrin~r Mannheim Corp., Indianapolis, IN)and 10  -5 M arabinosine 
cytosine C (ARAC).  On day 4, after plating culture medium was renm,a.~d 
but ARAC was omitted. Neurons were microinj¢~a~! between day 5-7 of 
culture.  3 h after injection, neurons were fed with fresh medium without 
NGF,  2.5%  rat serum and antibodies to NGF  (Boehringar Mannheim 
Corp.). 
Microinjections 
Sympathetic  neurons were microinjected 5-7 d after plating as previously 
described (17). Before injection, cultures were washed with fresh medium. 
All neurons within an area that was marked on the bottom of the culture 
dish were micminjected with a low pressure microinjvction system (auto- 
matic injector Inject +  Marie, Geneva). The DNA constructs were diluted 
in water, 0.5 mg/ml FITC-dextran,  at concentrations of 0.01-0.1 mg/ml. 3 h 
after injection neurons were counted to determine the initial size of the in- 
jected population.  Approximately 85% of injected nearons survived the 
stress caused  by injection. 
Survivai  Assay 
For determination of cell viability, the dye 3-(4,5-dimethyRhiazol-2-yl)-2,5 
diphenyl tetrazolium bromide (MTT), which is converted to insoluble pur- 
ple formazan crystals by the mitochondrial debydro~nases of living cells, 
was added to the culUa'¢ medium at 0.5 rag/m1. Cells were incubated at 
37°C for 20 rain and positive neurons counted under light microscopy (35). 
HOECHST dye #33342,  a DNA minor groove-binding  ligand was added 
to the culture medium simultammus  to MTT.  Chromafin staining was 
viewed under ultraviolvt  fluorescence. 
lmmunocytochemistry 
Neurons were fixed with 4% paraformuldehyde  in PBS, permeab'~  for 
10 rain with 0.2 % Triton X-100 in PB$, and incubated for 2 h with monnelo- 
hal antibodies to E1A (48), E1B19K, or Bcl-2 (Cambridge Research Labora- 
tories, Wilmington, DE) followed by FITC-conjugated  goat anti-mouse an- 
tibody. 
Plasmid Constructions 
Constructions of E1B19K, E1B55K, and E1A expression vectors has been 
described previously  (45-47).  Construct for Bcl-2 expression was  de- 
scribed in (17). 
The baculovirus  P35 gane was cloned by PCR using synthetic oligo- 
nucleotides  based upon its published sequence (16). Tails including ClaI 
sites were A  dd~ to each end resulting in 5'-TTAATTAATTAAATCGATT- 
ATGTGTGTAATTTTICCGGTAGA  for the amino terminus and TACTGA- 
TATTAAATCGATTTATTTAATTGTGTTTAATA'IWACATTA for the car- 
boxy terminus. PCR was conducted for 20 cycles using 20 ng of purified 
wild-type baculovirus DNA as template. The amplified DNA fragment was 
1. Abbreviations used in this paper: ARAC, arabinosine cytosine C; MTT, 
3-(4,5-dimethylthiazol-2-yl)-2,5  diphenyl tetrazolium bromide; SCG, supe- 
rior cervical ganglia. 
digested by ClaI endonuclease and the resulting fragment of 900 bp inserted 
into the unique ClaI site present downstream of the hCMV promoter of the 
pEEl2  derivative.  Clones with the insert in the two orientations were 
selected.  The sequence  of the I'CR product was identical to the p35 se- 
qnence published by Friesen and Miller (1987) (16). 
The human Bcl-Xs eDNA was cloned by PCR using RNA from human 
thymus and synthetic oligunucleotides  based upon its published sequence 
(6). PCR was conducted for 35 cycles using the following oligonucleotides: 
GAGAATCACTAACCAGAGAC  for the amino terminus and AGGTGGTG- 
TA~GGT  for the carboxy terminus. The PCR product was am- 
plilied a second time using the following oligonuclectide:  ~.CAA- 
TGGACTGGTIUA for the 5' end and CTGGTCTGTGACTGGTAGGT  at 
the 3' end. Two DNA fragments of 760 and 572 bp were amplified and sub- 
cloned in the Sinai restriction site.of pBlnescript (Stratngene, La Jolla, CA) 
and sequenced.  The 760-bp long fragment corresponded to Bcl-XI and the 
572-bp fragment was identical to Bcl-Xs. Bcl-Xs was excised from pBlne- 
script with EcoRI and XbaI and subcloned in pcDNA 1 (Invitrogan,  San 
Diego,  CA). All plasmid DNA used for microinjections were purified on 
a cesium chloride gradient. 
Results 
SCG Neurons Depend on NGF  for Their Survival 
Neurons dissociated from superior cervical ganglion of new- 
born rats were maintained in culture for 5-7 d in the presence 
of NGF.  Under  these  con&dons,  they  maintained  phase 
bright  cell bodies and a dense neurite network (Fig.  1 A). 
The viability of neurons was demonstrated by a metabolic 
reduction of MTT  (Fig.  1 B),  which stains purple in the 
cytoplasm of cells with functional mitochondria  (35)  and 
a nuclear-HOECHST  dye  staining  (Fig.  1  C).  24 h  after 
removal of NGF from the culture medium, the neurons still 
&splayed bright cell bodies but their cytoplasm was slightly 
reduced in size and appeared granular. In particular, the nu- 
cleus and nucleolus were less visible (not shown). After 48 h 
in the absence of NGF,  most neurons were MTT negative 
and &splayed nuclear condensation which is a hallmark of 
apoptosis (Fig.  1, D, E, and F) (28, 50). Nuclear pyknosis 
s~med to precede loss of mitochondrial function as a small 
percentage  of neurons  that  &splayed  condensed  nucleus 
were still MTT positive (not shown). Atrophy of the cell bod- 
ies was followed by neurite disintegration. 
Effects of EIB and p35 on the Surviml 
of Sympathetic Neurons 
cDNAs encoding EIB19K, E1B55K  from adenovirus under 
control of the CMV promoter (45), and p35 from baculovi- 
rus also under control of the CMV promoter, were used to 
assess the ability of these proteins to regulate apoptosis. The 
purified  DNA  was microinjected  into the  nucleus  of 5-7 
d-old sympathetic neurons. 3 h after microinjection, NGF was 
removed and antibodies against NGF added to the culture 
medium. In all experiments,  100%  cell survival referred to 
the number of living neurons counted 3 h after NGF depriva- 
tion. 2 d later, less than 10% of neurons that were not in- 
jected  or  were  injected  with  control  DNA  survived.  We 
repeatedly observed that neurons that were microinjected 
with only FITC-dextran in water survived better during the 
first 24 h after NGF deprivation compared to uninjected neu- 
rons.  The beneficial effects due to microinjecdon per  se 
never lasted more than 24 h and by 48 h after injection the 
survival of microinjected and unlnjected neurons was not 
different (this observation is reported in Fig. 6). At that time, 
,o10% of neurons injected with a control DNA solution sur- 
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pathetic  neurons  undergoing 
apoptosis after NGF depriva- 
tion.  Neurons  from cervical 
superior  ganglia  of newborn 
rats  were maintained  in cul- 
ture for 5-7 d in the presence 
of NGE  Under these  condi- 
tions,  they  maintained  phase 
bright cell bodies (A). MTT 
and  HOECHST  staining 
confirmed  their  viability  (B 
and C). 48-h after NGF depri- 
vation,  the majority  of neu- 
rons  were  dead.  Their  cell 
bodies and neurites were dis- 
integrated  (D).  HOECHST 
staining revealed nuclear con- 
densation  and  the  MTT test 
an absence  of mitechondrial 
f3mction  (E  and  F).  Bar, 
50/zm. 
rived NGF deprivation. In contrast,  ,x,60% of neurons in- 
jected with EIB19K (Fig. 2 A and Fig. 3) or p35 (Fig. 2 B) 
survived in the absence of NGE  These neurons could be 
maintained alive for at least 7 d in the absence of NGE Their 
cell  body  and  neurites  were however atrophied  (Fig.  3). 
These observations are similar to those we previously made 
for Bcl-2 (17).  This suggests that these anti-apoptotic pro- 
teins display survival but not trophic effects. 
Neither EIB55K, another adenoviral protein, nor pm7fs, 
a frameshift mutant of E1B19K (47), had beneficial effects on 
neuronal survival (Fig.  2 A). 
Bci-Xs Can Inhibit the Ability of  Bcl-2 but Not of 
EIBI9K or p35 to Prevent Apoptotic Cell Death 
Boise et al.  (6) have recently reported that cocxpression of 
Bcl-2 with Bcl-Xs, a  splice variant of Bcl-X, inhibits Bcl-2 
from preventing apoptotic death of FL5.12 cells upon growth 
factor removal. We have tested whether Bcl-Xs could block 
the  anti-apoptotic function of Bcl-2,  E1B19K,  and p35  in 
SCG neurons.  Bcl-2, E1B19K,  and p35 were injected at a 
concentration of 0.01 ~g/~l with increasing concentrations of 
Bcl-Xs ranging from 0 to 0.1 ~g/~,l./%galactosidase was used 
as a  control for Bcl-Xs.  We found that Bcl-Xs inactivated 
Bcl-2 function in a  dose-dependent fashion (Fig.  4  A).  A 
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Figure 2.  Effects of overexpression of E1B19K, EIB55K, and p35 
on neuronal  survival.  5-7 d  cultured  sympathetic  neurons  were 
microinjected  with  different  plasmids  encoding  EIB19K  and 
E1B55K adenoviral  proteins  and p35  protein  from be~ulovirus. 
pm7fs, a frame shift mutant of EIB19K and a plasmid containing 
p35 cDNA in an antisense orientation  were used as controls. For 
each experiment, different pools of neurons (between 100 and 200) 
contained  in  rectangles  labeled  on  the  bottom of 3.5-cm  petri 
dishes were microinjected with different plasmids. 3 h after micro- 
injection neurons were deprived Of  NGE Neuronal survival was as- 
sayed 48 h later and is expressed as the percentage of neurons at 
the time of NGF deprivation.  Results are mean +  SE for 6 and 2 
experiments in A and B, respectively. In A, we have included the 
result of a microinjection with Bcl-2 that was performed in one of 
the six experiments. 
Martinou et al. E1BI9K  and p35 Block Neuronal Programmed Cell Death  203 Figure 3. Appearance of ElB19K-micminjected neurons after NGF deprivation.  Neurons have been microinjected  with E1B19K expression 
vector and deprived of NGF. Their morphology was analyzed after 2 d (B) and 7 d (C) and compared to that of neurons cultured in the 
presence of NGF (A) or uninjected neurons deprived of NGF for 2 d (D). Expression of EIBI9K was assessed by immunostaining  (E, 
phase microscopy;  F, fluorescence  microscopy).  Bar, 30/~m. 
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Figure 4. Effects of Bcl-Xs on 
the rescuing effects of Bcl-2, 
E1B19K, and p35.  (A)  Sym- 
pathetic  neurons were micro- 
injected with expression  vec- 
tors for Bcl-2 and BcI-Xs. An 
expression vector for fl-galac- 
tosidase was used as a control 
for  Bcl-Xs.  Bcl-2  alone was 
also  tested  in  these  experi- 
ments. The ratio of concentra- 
tions  of  BcI-Xs  or  /3-galac- 
tosidase  over  Bcl-2  varied 
from 1 to 5. Neurons were as- 
sayed for survival 48 h after 
NGF deprivation. Results rep- 
resent the percentage of neu- 
ronal  survival  promoted  by 
Bcl-2 alone considered here as 
100%  survival. In three  in- 
dependent  experiments  we 
found that the number of sur- 
viving neurons coinjected with Bcl-2 and Bcl-Xs was reduced by 41%  +  3 compared to the number of neurons injected with Bcl-2 and 
/3-galactosidase. (B) The effects of BcI-Xs were also tested on the survival effects of EIBI9K and p35. Neurons were coinjected with expres- 
sion vectors for E1B19K  or p35 and Bcl-Xs. The DNA concentration  of Bcl-Xs expression vector was in a 10-fold excess over that of EIBI9K 
or p35 expression vector.  The results are the mean (bar height) and standard error (error bar) of n experiments.  Between 100 and 200 
neurons were injected in each experiment. 
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hag Bel-2 and BcI-Xs undergo 
programmed cell  death  after 
NGF  deprivation.  Neurons 
have been coinjected with ex- 
pression vectors for Bel-2 and 
B-galactosidase (,4, B, and C) 
or Bcl-2 and BcI-Xs (D, E, and 
F)  and  deprived  of  NGE 
Three  days  later,  they  were 
immunostained  for Bel-2  (B 
and E) and their nucleus vi- 
sualized by HOECHST stain- 
ing (Cand F). In D, three neu- 
rons undergo programmed cell 
death;  two of them indicated 
by arrows display nuclear con- 
densation despite Bcl-2 over- 
expression.  Bar, 20 ttm. 
large proportion of neurons overexpressing Bcl-2 and Bcl-Xs 
displayed  nuclear  condensation  visualized by  HOECHST 
staining.  A picture of such a neuron is shown in Fig. 5. In 
contrast, BcI-Xs had no effect on the function of EIB19K and 
p35; even when the concentration of the vector for Bcl-Xs 
expression was in a  10-fold excess over that containing p35 
or E1B19K,  no adverse effect was observed on the protective 
function of both proteins (Fig. 4 B). To rule out the possibil- 
ity that Bcl-Xs expression may have altered Bcl-2 expression, 
we measured the level Bcl-2 in the presence or absence of 
coinjected Bcl-Xs, by immunostaining using a confocal mi- 
croscope. Immunofluorescence intensity of neurons injected 
with expression vectors for Bcl-2 alone was not significantly 
different from that of neurons injected with Bcl-2 together 
with BcI-Xs or #-galactosidase. The fluorescence levels de- 
tected and expressed in arbitrary units were: Bcl-2:208  + 
43; Bel-2 and/3-galactosidase: 193  +  55; Bcl-2 and Bcl-Xs: 
188  5: 59,  mean 5: SD for 20 neurons analyzed. Therefore 
the  inhibition  of Bcl-2 activity observed upon coinjection 
with Bel-Xs cannot be accounted for by a drop in Bcl-2 ex- 
pression. 
Bci-Xs Does Not Interfere with Survival Effects of NGF 
Neurons injected with Bel-Xs alone were left in the presence 
of NGF for up to a week. Under these conditions, BcI-Xs had 
no deleterious effect on neuronal survival (not shown). Also 
the kinetic of cell death after NGF withdrawal was not de- 
tectably affected (Fig.  6). 
E1A Does Not Affect Neuronal Survival 
Previous  studies  have  shown  that  E1A  expression  is 
detrimental to cell viability. We have tested whether this pro- 
tein may have a similar effect on postmitotic neurons.  E1A 
expression was detected after DNA injection using a mono- 
clonal antibody to the protein.  The E1A protein was only 
localized in the nucleus but not within the nucleolus  (Fig. 
7 A). Neurons overexpressing the E1A protein did not show 
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Figure 6. Effects of Bcl-Xs on neuronal survival. Sympathetic neu- 
rons were microinjected with expression vectors containing BcI-Xs 
and their survival compared to that of uninjected neurons for 4 d 
after NGF deprivation.  Results are mean  +  SE for two experi- 
ments. 
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Figure 7.  Effects of EtA overexpression on the survival of sym- 
pathetic neurons. Sympathetic  neurons were microinjected  with an 
expression vector for EtA.  (A) 24 h later the neurons were im- 
munostained for EtA and analyzed with a confocal  microscope. (B) 
Kinetic of survival of neurons overexpressing  EtA in the presence 
of NGE 
in the presence or 24 h after deprivation of NGF. In particu- 
lar no bromodeoxyuridine incorporation could be detected 
indicating the absence of DNA synthesis (not shown). Fur- 
thermore, cell death in the presence of NGF was not affected 
by overexpression of E1A (Fig. 7 B). 
Discussion 
Several  viral genes  such as the baculovirus p35  gene (9, 
11,  23),  the Epstein-Barr virus latent genes (19, 21,  22), 
adenovirus E1B (39),  and the herpes simplex virus neuro- 
virulence gene (8)  encode proteins that can protect cells 
from apoptosis induced upon viral infection. These genes 
promote viral intracellular persistence and allow viral repli- 
cation within the infected cell. In the case of the adenovirus, 
E1B genes are necessary for transformation since they block 
apoptosis induced by the oncogenic activity of E1A (47). 
Here we have used two viral proteins, E1B19K from adenovi- 
rus and p35 from baculovirus, as tools to get insights into 
the mechanisms by which postmitotic neurons die after neu- 
rotrophic factor deprivation. We report that independently of 
viral infection, the two viral proteins can block apoptosis in- 
duced by neurotrophic factor deprivation in neurons. These 
proteins 'are as efficient as the Bcl-2 protooncogene which 
protects neurons from apoptosis induced in similar condi- 
tions (1, 4,  17, 31). 
Bcl-2  can protect a  vast array of vertebrate and inver- 
tebrate cells against cell death (for review see reference 40). 
This suggests that the basic mechanisms driving cell death 
are common to most cells and highly conserved throughout 
evolution. However, it is noteworthy that Bcl-2 does not pro- 
tect in every case of apoptosis: it does not rescue target cells 
from cytotoxic T cell killing, neither does it rescue all cell 
lines from cytokine deprivation, T cells from Thy-1 antibody 
induced apoptosis (for review see reference 40), nor chicken 
ciliary neurons from ciliary neurotrophic factor deprivation 
(1). Finally, we have evidence that in transgenic mice, over- 
expression of Bcl-2 does not protect all neurons from natu- 
rally occurring cell death (33).  Therefore, upon particular 
stimuli, cells may use pathways that escape Bcl-2 protection. 
In an effort to sort out cell death pathways it may be very rele- 
vant to test whether EIB and p35 are able to block apoptosis 
in  situations  where  Bclo2  has  failed to  inhibit this  phe- 
nomenon. 
Recently, Boise et al. (6) reported the cloning of Bcl-X, 
a gene highly homologous to Bcl-2. Two splice variants en- 
coding a long and a short form of BcI-X were described. A 
long form, Bcl-Xl seems to function interchangeably with 
Bcl-2. Bcl-X1 mRNA is strongly expressed in tissues con- 
taining long-lived cells such as adult brain. The short spliced 
product, Bcl-Xs, lacks a 63-amino acid region that is highly 
conserved between different members of the Bcl-2 family. 
Bcl-Xs has no anti-apoptotic activity but instead inhibits Bcl-2 
function (6).  Since Bcl-Xs does not interact with Bcl-2, the 
current hypothesis is that it acts as a dominant negative mu- 
tant of  Bcl-2 by competing for and blocking effector  proteins. 
Although p35 does not display obvious amino acid sequence 
homology with Bcl-2 and although the homology between 
Bci-2 and E1BI9K is limited (7), they could however interact 
with common effectors. We have used Bcl-Xs to test this hy- 
pothesis. Similar to the findings described by Boise et al. (6) 
using an IL-3-dependent cell line, we found that Bcl-Xs re- 
duced the rescuing effect of Bcl-2 on neurons deprived of 
NGE However Bcl-Xs had no influence on the anti-apoptotic 
activity of p35 and of E1B19K. Although we cannot exclude 
that the failure of Bcl-Xs to block E1B19K and p35 simply 
reflects a higher activity of these two proteins over that of 
Bcl-2, these findings suggest that E1B19K, p35,  and Bcl-2 
display different mechanisms of action. In favor of this hy- 
Ix)thesis, it was shown that actinomycin  D-induced apoptosis 
in SF-21 cells can be blocked by p35 hut not by Bcl-2 nor 
by E1B19K (10). 
Very little is known about the molecules which mediate the 
surviving activity of NGF. Recently Bcl-2 and Bcl-X1 have 
been shown to be expressed in neurons during development 
and in adulthood (6).  The ability of these proteins to rescue 
neurons from neurotrophin deprivation, suggested that they 
may represent downstream effectors of neutrophins. How- 
ever Bcl-Xs,  which blocks Bcl-2 function, had no deleteri- 
ous effect on SCG neurons. This suggests that neither Bcl-2 
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pathway. 
Apoptosis has recently  been hypothesized to be the re- 
sult of aberrant cell-cycle control. In favor of this, Shi et al. 
(42) have shown that activation  of p34cdc2 is required for 
apoptosis induced by a cytotoxic granule protease.  Another 
common feature between apoptosis and mitosis has been 
described by Freeman et al.  (15): Cyclin D1, a protein pre- 
viously shown to be essential for progression through the 
GI phase of the cell cycle, is selectively induced in SCG neu- 
rons undergoing  cell death after NGF deprivation.  In rela- 
tion to this, we have examined the effect of EtA overexpres- 
sion in postmitotic neurons.  EtA expression is sufficient to 
initiate proliferation of primary baby rat kidney cells and fo- 
cus formation. The ability of EtA to stimulate cellular DNA 
synthesis accompanies the induction of apoptosis (46). After 
a  discrete  number of divisions,  these  cells  will  undergo 
apoptosis mediated by p53 (12, 47). In neurons, expression 
of EtA for several days had no deleterious effect on survival. 
The lack of EtA toxicity in neurons could be due to the inca- 
pacity of neurons to replicate DNA. Our results further sup- 
port the idea that cell death induced by EtA represents only 
an undesirable side effect of the proliferation induced by the 
protein and not a toxic effect of the protein per se. The lack 
of protective effect of E1B55K on neurons deprived of NGF 
underlines the molecular differences between mechanisms of 
cell-death  in proliferating vs non-proliferating  cells. Indeed 
E1B55K blocks apoptosis of proliferating cells by binding to 
p53 and directly blocking its activity  (41, 51).  Sympathetic 
neurons express p53 (15).  The lack of rescuing  activity  of 
E1B55K strongly  suggests that p53 is unnecessary for neu- 
ronal death induced by NGF deprivation. 
In  summary,  we  have  shown  that  two  viral  proteins 
E1B19K and p35 are capable of rescuing pestmitotic neurons 
from cell death  induced upon NGF withdrawal.  We also 
demonstrated  that Bcl-Xs antagonizes  the rescuing  activity 
of Bcl-2 but not of p35 or E1B19K. Understanding the func- 
tion of these proteins should allow the identification  of key 
components of neuronal cell death pathways. 
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